1. Home
  2. MRK
  3. MRK News

Latest Merck & Company Inc. (new) (MRK) News on November 16, 2025

Cidara Therapeutics (CDTX) Skyrockets 105% on Merck $9.2-Billion Acquisition Bid
MRK

Insider Monkey

21 hours ago

Cidara Therapeutics (CDTX) Skyrockets 105% on Merck $9.2-Billion Acquisition Bid

Companies Like Marks Electrical Group (LON:MRK) Are In A Position To Invest In Growth
MRK

Simply Wall St.

a day ago

Companies Like Marks Electrical Group (LON:MRK) Are In A Position To Invest In Growth

Dow Drops For Second Day Amid Uncertainty Around December Rate Cut
MRK

MT Newswires

a day ago

Dow Drops For Second Day Amid Uncertainty Around December Rate Cut

Merck Swoops In On Buyout Bonanza With A $9.2 Billion Cidara Therapeutics Deal
MRK

Investor's Business Daily

2 days ago

Merck Swoops In On Buyout Bonanza With A $9.2 Billion Cidara Therapeutics Deal

MRK

MT Newswires

2 days ago

Sector Update: Health Care Stocks Ease Late Afternoon

MRK

MT Newswires

2 days ago

US Equity Indexes Mixed Amid Technology Rebound

This Biotech's Stock Price More Than Doubled on Friday. Here's Why.
MRK

Investopedia

2 days ago

This Biotech's Stock Price More Than Doubled on Friday. Here's Why.

MRK

ACCESS Newswire

2 days ago

RedChip Companies Congratulates Former Client Cidara Therapeutics on Its $9.2 Billion Acquisition by Merck

Stocks to Watch Friday: Walmart, Cidara, Warner Bros.
MRK

The Wall Street Journal

2 days ago

Stocks to Watch Friday: Walmart, Cidara, Warner Bros.

MRK

Financial Times

2 days ago

Merck agrees $9.2bn deal for flu-prevention biotech Cidara

MRK

MT Newswires

2 days ago

Sector Update: Health Care Stocks Decline Premarket Friday

MRK

MT Newswires

2 days ago

Wall Street Weighs Tech Valuations, Fed Outlook as US Equity Futures Fall Pre-Bell

Merck to Acquire Cidara Therapeutics in $9.2 Billion Deal
MRK

MT Newswires

2 days ago

Merck to Acquire Cidara Therapeutics in $9.2 Billion Deal

Do You Believe in Merck & Co.’s (MRK) Upside Potential?
MRK

Insider Monkey

2 days ago

Do You Believe in Merck & Co.’s (MRK) Upside Potential?

This Biotech Stock Is Soaring 100%. Merck Is Buying It.
MRK

Barrons.com

2 days ago

This Biotech Stock Is Soaring 100%. Merck Is Buying It.

Pharma ETFs in Spotlight Following Robust Q3 Earnings Results
MRK

Zacks

2 days ago

Pharma ETFs in Spotlight Following Robust Q3 Earnings Results

Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls
MRK

The Fly

3 days ago

Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls

Merck to Participate in the Jefferies Global Healthcare Conference in London
MRK

Business Wire

3 days ago

Merck to Participate in the Jefferies Global Healthcare Conference in London

MRK

MT Newswires

3 days ago

Scotiabank Initiates Merck & Co. at Sector Outperform With $105 Price Target

Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead?
MRK

Motley Fool

3 days ago

Should You Forget Pfizer and Buy This Magnificent Drug Stock Instead?

1 Incredible Reason to Buy LLY's Stock in November
MRK

Motley Fool

3 days ago

1 Incredible Reason to Buy LLY's Stock in November

MRK

MT Newswires

4 days ago

Merck & Co. Insider Sold Shares Worth $616,395, According to a Recent SEC Filing

Merck (MRK) Is Up 8.5% After Promising Oral PCSK9 Cholesterol Drug Trial Results – Has The Bull Case Changed?
MRK

Simply Wall St.

4 days ago

Merck (MRK) Is Up 8.5% After Promising Oral PCSK9 Cholesterol Drug Trial Results – Has The Bull Case Changed?

2 Strong Healthcare Stock Picks for Value Investors
MRK

Motley Fool

4 days ago

2 Strong Healthcare Stock Picks for Value Investors

2 Stocks Down 13% and 34% to Buy Right Now
MRK

Motley Fool

4 days ago

2 Stocks Down 13% and 34% to Buy Right Now

Stocks Gain Pre-Bell Ahead of Looming House Vote to End Government Shutdown
MRK

MT Newswires

4 days ago

Stocks Gain Pre-Bell Ahead of Looming House Vote to End Government Shutdown

Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know
MRK

StockStory

5 days ago

Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know

Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know
MRK

StockStory

5 days ago

Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know

Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know
MRK

StockStory

5 days ago

Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know

Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know
MRK

StockStory

5 days ago

Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know

Elevance Health, Labcorp, Privia Health, Fortrea, and Amgen Shares Are Soaring, What You Need To Know
MRK

StockStory

5 days ago

Elevance Health, Labcorp, Privia Health, Fortrea, and Amgen Shares Are Soaring, What You Need To Know

Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know
MRK

StockStory

5 days ago

Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know

Merck’s Heart Pill Slashes Cholesterol Levels in Test Patients
MRK

Barrons.com

5 days ago

Merck’s Heart Pill Slashes Cholesterol Levels in Test Patients

Top 3 Dividend Stocks To Enhance Your Portfolio
MRK

Simply Wall St.

6 days ago

Top 3 Dividend Stocks To Enhance Your Portfolio

Will Keytruda Aid MRK's Growth in 2026 After a Subdued Q3?
MRK

Zacks

6 days ago

Will Keytruda Aid MRK's Growth in 2026 After a Subdued Q3?

AIM ImmunoTech Details New UPMC Abstract on Completed Clinical Trial Involving Ampligen’s Synergistic Potential in the Treatment of Advanced Recurrent Ovarian Cancer
MRK

GlobeNewswire

6 days ago

AIM ImmunoTech Details New UPMC Abstract on Completed Clinical Trial Involving Ampligen’s Synergistic Potential in the Treatment of Advanced Recurrent Ovarian Cancer

Bristol Myers Gains 7.2% in a Month: Buy, Sell or Hold the Stock?
MRK

Zacks

6 days ago

Bristol Myers Gains 7.2% in a Month: Buy, Sell or Hold the Stock?

MRK

MT Newswires

6 days ago

Leerink Partners Adjusts Price Target on Merck to $114 From $107

Factbox-Major deals involving U.S. drugmakers and biotechs over the past decade
MRK

Reuters

6 days ago

Factbox-Major deals involving U.S. drugmakers and biotechs over the past decade

MRK

MT Newswires

6 days ago

Merck's Phase 3 Trial of Enlicitide Decanoate in Heterozygous Familial Hypercholesterolemia Achieves Primary Endpoint

Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Adults with Heterozygous Familial Hypercholesterolemia (HeFH) in Phase 3 CORALreef HeFH Trial
MRK

Business Wire

6 days ago

Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Adults with Heterozygous Familial Hypercholesterolemia (HeFH) in Phase 3 CORALreef HeFH Trial

More Drugs to Fight High Cholesterol Are Emerging
MRK

The Wall Street Journal

7 days ago

More Drugs to Fight High Cholesterol Are Emerging

Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60%
MRK

Investor's Business Daily

8 days ago

Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60%

Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Phase 3 CORALreef Lipids Trial
MRK

Business Wire

8 days ago

Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Phase 3 CORALreef Lipids Trial

Morgan Stanley Raises Merck (MRK) Price Target to $100, Maintains Equal Weight Rating
MRK

Insider Monkey

8 days ago

Morgan Stanley Raises Merck (MRK) Price Target to $100, Maintains Equal Weight Rating

Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock
MRK

Zacks

9 days ago

Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock

3 Dirt Cheap Stocks to Buy With $1,000 Right Now
MRK

Motley Fool

9 days ago

3 Dirt Cheap Stocks to Buy With $1,000 Right Now

Codexis Inc (CDXS) Q3 2025 Earnings Call Highlights: Strategic Shifts and New Partnerships ...
MRK

GuruFocus.com

9 days ago

Codexis Inc (CDXS) Q3 2025 Earnings Call Highlights: Strategic Shifts and New Partnerships ...

2 Safe-and-Steady Stocks Worth Your Attention and 1 We Turn Down
MRK

StockStory

9 days ago

2 Safe-and-Steady Stocks Worth Your Attention and 1 We Turn Down

Endometrial Cancer Market Poised for Expansion Throughout Forecast Period (2025-2034) Amid Increasing Adoption of Immunotherapies | DelveInsight
MRK

PR Newswire

9 days ago

Endometrial Cancer Market Poised for Expansion Throughout Forecast Period (2025-2034) Amid Increasing Adoption of Immunotherapies | DelveInsight

Codexis Reports Third Quarter 2025 Financial Results
MRK

GlobeNewswire

9 days ago

Codexis Reports Third Quarter 2025 Financial Results

Moderna Q3 Earnings Beat, Stock Up on Revised '25 Spending Plans
MRK

Zacks

10 days ago

Moderna Q3 Earnings Beat, Stock Up on Revised '25 Spending Plans

AZN Q3 Earnings Top Estimates, Sales Rise As Most Key Drugs Outperform
MRK

Zacks

10 days ago

AZN Q3 Earnings Top Estimates, Sales Rise As Most Key Drugs Outperform

PLANET HOME ANNOUNCES $1 MILLION TOUGH TECH PRIZE AT INAUGURAL GALA DURING TOUGH TECH WEEK
MRK

PR Newswire

10 days ago

PLANET HOME ANNOUNCES $1 MILLION TOUGH TECH PRIZE AT INAUGURAL GALA DURING TOUGH TECH WEEK

AstraZeneca CEO bullish on record revenue numbers and US growth
MRK

Yahoo Finance Video

10 days ago

AstraZeneca CEO bullish on record revenue numbers and US growth

3 Reasons Investors Love Merck (MRK)
MRK

StockStory

10 days ago

3 Reasons Investors Love Merck (MRK)

[Latest] Global Precision Swine Farming Market Size/Share Worth USD 2061.6 Million by 2034 at a 9.78% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
MRK

GlobeNewswire

11 days ago

[Latest] Global Precision Swine Farming Market Size/Share Worth USD 2061.6 Million by 2034 at a 9.78% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Alliance for Building Better Medicine and the Virginia Innovation Partnership Celebrate $120 Million Investment from AstraZeneca, Eli Lilly, and Merck to Advance Virginia's Advanced Pharmaceutical Manufacturing Workforce
MRK

PR Newswire

11 days ago

Alliance for Building Better Medicine and the Virginia Innovation Partnership Celebrate $120 Million Investment from AstraZeneca, Eli Lilly, and Merck to Advance Virginia's Advanced Pharmaceutical Manufacturing Workforce

Merck (MRK): Valuation Insights After Upbeat Q3, Oncology Growth, and Strategic Funding Progress
MRK

Simply Wall St.

11 days ago

Merck (MRK): Valuation Insights After Upbeat Q3, Oncology Growth, and Strategic Funding Progress

Quebec Expands Public Funding for CAPVAXIVE®
MRK

CNW Group

11 days ago

Quebec Expands Public Funding for CAPVAXIVE®

MSD secures $700m for broad-cancer ADC asset
MRK

Pharmaceutical Technology

11 days ago

MSD secures $700m for broad-cancer ADC asset

This Company Now Has the World's No. 1 Drug. Should You Invest $1,000?
MRK

Motley Fool

11 days ago

This Company Now Has the World's No. 1 Drug. Should You Invest $1,000?

MRK

MT Newswires

11 days ago

Merck & Co. Insider Sold Shares Worth $720,040, According to a Recent SEC Filing

MRK

MT Newswires

12 days ago

Sector Update: Health Care Stocks Rise Late Afternoon

Why Merck Is Sinking This Week
MRK

Motley Fool

12 days ago

Why Merck Is Sinking This Week

MRK

MT Newswires

12 days ago

Sector Update: Health Care Stocks Rise Tuesday Afternoon

Hyperlipidemia Drugs Market Report 2025: $24.74 Industry Led by Pfizer, Merck & AbbVie, With Asia-Pacific Poised for Strong Growth Amid Trade-Driven Supply Chain Shifts - Global Forecast to 2034
MRK

GlobeNewswire

12 days ago

Hyperlipidemia Drugs Market Report 2025: $24.74 Industry Led by Pfizer, Merck & AbbVie, With Asia-Pacific Poised for Strong Growth Amid Trade-Driven Supply Chain Shifts - Global Forecast to 2034

MRK

MT Newswires

12 days ago

Merck Signs Deal With Dr. Falk Pharma for MK-8690 Development, Commercialization Rights

MRK

MT Newswires

12 days ago

Merck to Receive $700 Million From Blackstone Unit to Support Experimental Cancer Drug Development

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More
MRK

24/7 Wall St.

12 days ago

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More

Should You Buy Moderna Stock Ahead of Q3 Earnings Report?
MRK

Zacks

12 days ago

Should You Buy Moderna Stock Ahead of Q3 Earnings Report?

Merck price target raised to $100 from $98 at Morgan Stanley
MRK

TipRanks

12 days ago

Merck price target raised to $100 from $98 at Morgan Stanley

Is Eli Lilly a Millionaire Maker?
MRK

Motley Fool

12 days ago

Is Eli Lilly a Millionaire Maker?

Pfizer's $4.9 Billion Gamble: Inside Its Legal War to Reclaim the Obesity Market
MRK

GuruFocus.com

12 days ago

Pfizer's $4.9 Billion Gamble: Inside Its Legal War to Reclaim the Obesity Market

ESMO 2025: Sichuan-Kelun moves in breast cancer ADC space
MRK

Pharmaceutical Technology

13 days ago

ESMO 2025: Sichuan-Kelun moves in breast cancer ADC space

Merck Foundation Launches $22 Million Initiative to Improve Cardiovascular Care in the U.S.
MRK

Business Wire

13 days ago

Merck Foundation Launches $22 Million Initiative to Improve Cardiovascular Care in the U.S.

ESMO 2025: Bayer and BI neck and neck in first line HER2+ NSCLC
MRK

Pharmaceutical Technology

13 days ago

ESMO 2025: Bayer and BI neck and neck in first line HER2+ NSCLC

Merck & Co. Inc. (MRK) Reports Solid Q3 with Strong Drug Sales and Pipeline Progress
MRK

Insider Monkey

13 days ago

Merck & Co. Inc. (MRK) Reports Solid Q3 with Strong Drug Sales and Pipeline Progress

2 Safe-and-Steady Stocks with Impressive Fundamentals and 1 We Avoid
MRK

StockStory

13 days ago

2 Safe-and-Steady Stocks with Impressive Fundamentals and 1 We Avoid

Results: Merck & Co., Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
MRK

Simply Wall St.

14 days ago

Results: Merck & Co., Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Alternative Economic Data Point to Solid Growth
MRK

Barrons.com

15 days ago

Alternative Economic Data Point to Solid Growth

The Craneware Group Hosts 340B Rebate Forum, Confirms No New Vendor Needed for Pilot
MRK

PR Newswire

16 days ago

The Craneware Group Hosts 340B Rebate Forum, Confirms No New Vendor Needed for Pilot

MRK

MT Newswires

16 days ago

Morgan Stanley Adjusts Price Target on Merck & Co. to $100 From $98

Merck Q3 2025 Earnings Call Transcript
MRK

Motley Fool

16 days ago

Merck Q3 2025 Earnings Call Transcript

MRK

MT Newswires

16 days ago

Goldman Sachs Adjusts Price Target on Merck & Co to $92 From $93

MRK

Morningstar Research

16 days ago

Analyst Report: Merck & Co., Inc.

Earnings live: Amazon stock soars, Apple CEO predicts 'best-ever' quarter; Exxon, Chevron post strong earnings
MRK

Yahoo Finance

16 days ago

Earnings live: Amazon stock soars, Apple CEO predicts 'best-ever' quarter; Exxon, Chevron post strong earnings

Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer
MRK

GlobeNewswire

16 days ago

Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer

Merck (MRK) Margin Expansion Tops Narratives With 19.4% EPS Growth and 25.8% Profit Margin
MRK

Simply Wall St.

16 days ago

Merck (MRK) Margin Expansion Tops Narratives With 19.4% EPS Growth and 25.8% Profit Margin

Earnings live: Amazon stock soars, Apple CEO predicts 'best-ever' holiday quarter, Reddit and Coinbase rise
MRK

Yahoo Finance

17 days ago

Earnings live: Amazon stock soars, Apple CEO predicts 'best-ever' holiday quarter, Reddit and Coinbase rise

Stocks to Watch Thursday Recap: Eli Lilly, Metsera, Navan, Chipotle
MRK

The Wall Street Journal

17 days ago

Stocks to Watch Thursday Recap: Eli Lilly, Metsera, Navan, Chipotle

Merck & Co Inc (MRK) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges
MRK

GuruFocus.com

17 days ago

Merck & Co Inc (MRK) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges

Dow Jones Stock Merck Tops Expectations, But Gardasil Challenges Remain
MRK

Investor's Business Daily

17 days ago

Dow Jones Stock Merck Tops Expectations, But Gardasil Challenges Remain

MRK

Investing.com

17 days ago

Moderna stock soars after report of potential buyout talks

Bladder Cancer Market - Global and Regional Analysis and Forecast (2025-2035) Featuring Merck & Co., Bristol Myers Squibb, Astellas Pharma, AstraZeneca, and Johnson & Johnson
MRK

GlobeNewswire

17 days ago

Bladder Cancer Market - Global and Regional Analysis and Forecast (2025-2035) Featuring Merck & Co., Bristol Myers Squibb, Astellas Pharma, AstraZeneca, and Johnson & Johnson

MRK Beats Q3 Earnings Estimates, Narrows 2025 Sales View, Stock Down
MRK

Zacks

17 days ago

MRK Beats Q3 Earnings Estimates, Narrows 2025 Sales View, Stock Down

Merck Stock Falls. Sales of Key Products Missed Estimates.
MRK

Barrons.com

17 days ago

Merck Stock Falls. Sales of Key Products Missed Estimates.

Apple & Amazon earnings, Fed, mortgage rates: What to Watch
MRK

Yahoo Finance Video

17 days ago

Apple & Amazon earnings, Fed, mortgage rates: What to Watch

Earnings live: Meta stock tumbles, Microsoft slides, and Alphabet rises as Big Tech earnings pour in
MRK

Yahoo Finance

18 days ago

Earnings live: Meta stock tumbles, Microsoft slides, and Alphabet rises as Big Tech earnings pour in

Merck Reports Earnings Under Shadow of Keytruda Patent Cliff. What to Expect.
MRK

Barrons.com

18 days ago

Merck Reports Earnings Under Shadow of Keytruda Patent Cliff. What to Expect.

Share on Social Networks: